Researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
Researchers at The Miriam Hospital demonstrated a practical strategy for regularly screening HIV-infected patients for acute hepatitis C virus infection (HCV), a "silent epidemic" that is rising undetected in this population ...
HIV & AIDS
Oct 18, 2011 |
not rated yet |
0
New study adds further guidance on when to start antiretroviral therapy for HIV
One of the key decisions faced by people living with HIV, and by their health-care providers, is when to start treatment.
HIV & AIDS
Sep 26, 2011 |
5 / 5 (1) |
0
|
Early antiretroviral therapy for HIV shown cost-effective
Researchers at Weill Cornell Medical College and GHESKIO (Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes) have shown that early treatment of HIV not only saves lives but is also cost-effective. ...
HIV & AIDS
Sep 21, 2011 |
not rated yet |
0
Gene therapy reduces HIV levels in small trials
(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...
HIV & AIDS
Sep 20, 2011 |
4.8 / 5 (4) |
0
|
Scientist develops virus that targets HIV
In what represents an important step toward curing HIV, a USC scientist has created a virus that hunts down HIV-infected cells.
HIV & AIDS
Aug 08, 2011 |
5 / 5 (2) |
1
|
HIV patient care by clinic nurses rather than hospital doctors clinically successful, cost effective
Transferring care of HIV patients from doctors in hospitals to nurses in primary health clinics is both clinically successful and cost effective
HIV & AIDS
Jul 19, 2011 |
not rated yet |
0
HIV therapies provide near normal lifespan in Africa
A landmark study by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia (UBC) shows that patients in Africa receiving combination antiretroviral therapy (cART) for HIV can expect to live ...
HIV & AIDS
Jul 18, 2011 |
5 / 5 (1) |
2
New drug adds to arsenal against AIDS
A new drug, rilpivirine, can add powerfully to the combination of medications used to control HIV for first-time patients, researchers conclude in Friday's issue of The Lancet.
HIV & AIDS
Jul 15, 2011 |
3 / 5 (1) |
0
New study confirms the existence of 'trial effect' in HIV clinical trials
A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a "trial effect" in clinical trials for treatment of HIV.
HIV & AIDS
Jul 13, 2011 |
3 / 5 (1) |
0
IAS urges Russian government to radically reassess counterproductive drug policies
28 June 2011. Geneva, Switzerland. As Boris Gryzlov, speaker of the Russian state Duma, calls for a "total war on drugs" to tackle Russia's growing drug problem, the International AIDS Society (IAS) urges the Russian government ...
HIV & AIDS
Jun 27, 2011 |
not rated yet |
0
Many of those living with HIV face a new life-threatening challenge: cancer
As the world marks the 30-year anniversary of the first reporting of HIV/AIDS, now comes the realization of a new challenge for people with the incurable disease. For reasons not yet clear, people with HIV face a higher ...
HIV & AIDS
Jun 06, 2011 |
not rated yet |
0
HIV drug could prevent cervical cancer
A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.
Medications
May 03, 2011 |
not rated yet |
0
|
One drug, many targets: Finding molecular targets of an HIV drug used in cancer therapy
Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why ...
Medications
Apr 28, 2011 |
5 / 5 (1) |
0
|
